Avaleht › Ülekaalulisus › Illinois
Ülekaalulisus kliinilised uuringud osariigis Illinois
38 uuringut haiguse Ülekaalulisus jaoks otsivad osalejaid osariigis Illinois.
Linnad osariigis Illinois
- Chicago28 uuringut
- Evanston9 uuringut
- Arlington Heights4 uuringut
- Cicero4 uuringut
- Champaign3 uuringut
- Waukegan3 uuringut
Ametlik uuringutekst (inglise keeles)
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Great Lakes Clinical Trials - West Wilson Avenue /ID# 282378, Chicago
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 2. okt 2026 · NCT07752979Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- Charter Research LLC - Chicago, Chicago
- Flourish Research - Chicago, Chicago
- AMR Clinical - Chicago Oak Brook, Oak Brook
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 29. sept 2026 · NCT07685808Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- Christie Clinic, Champaign
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 28. sept 2026 · NCT07837973AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Great Lakes Clinical Trials, Chicago
- Clinical Investigation Spec Gurnee, Gurnee
- Endeavor Health, Skokie
- ja veel 1
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07720271A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- Chicago Research Center, Inc, Chicago
- Endeavor Health, Skokie
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07668414A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Great Lakes Clinical Trials - Ravenswood, Chicago
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07794579A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Cedar Crosse Research Center, Chicago
- Northwestern University, Chicago
- Endeavor Health - Family Medicine Administration, Evanston
- ja veel 1
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07595549A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Champaign
- Research Site, Chicago
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT07776509Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Rush University Medical Center, Chicago
VärbamineFaas 3
Vanused 18–70 · Kõik sood · Uuendatud 24. sept 2026 · NCT06937099A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Ann and Robert Lurie Children's Hospital of Chicago, Chicago
- University of Illinois at Chicago, Chicago
VärbamineFaas 3
Vanused 6–17 · Kõik sood · Uuendatud 24. sept 2026 · NCT06672549Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Rush University Medical Center, Chicago
VärbamineFaas 3
Vanused 18–70 · Kõik sood · Uuendatud 24. sept 2026 · NCT06937086A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- NorthShore University Health System, Skokie
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Great Lakes Clinical Trials - Ravenswood, Chicago
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07392190A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Chicago
- Research Site, Melrose Park
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07784270Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Endeavor Health-Northwest Community Healthcare, Arlington Heights
- Eagle Clinical Research, Chicago
- University of Chicago, Chicago
- ja veel 2
VärbamineFaas 3
Vanused 45–99 · Kõik sood · Uuendatud 22. sept 2026 · NCT07037433Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Great Lakes Clinical Trials - Ravenswood, Chicago
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07353931A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- Great Lakes Clinical Trials - Ravenswood, Chicago
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 22. sept 2026 · NCT07589608A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Schaumburg
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. sept 2026 · NCT07743463A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Schaumburg
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. sept 2026 · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Elevate Clinical Research, Gurnee
- Knownwell, Schaumburg
- Endeavor Health, Skokie
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 14. sept 2026 · NCT07351045AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- University Of Chicago, Chicago
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 11. sept 2026 · NCT07571005AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Chicago Research Center, Inc, Chicago
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 9. sept 2026 · NCT07571109A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- Great Lakes Clinical Trials - Ravenswood, Chicago
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 8. sept 2026 · NCT06143956A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
- Walgreens - Store 11760, Oak Park
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 4. sept 2026 · NCT07745504Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Skokie
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 3. sept 2026 · NCT07284901Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Flourish Research - Great Lakes Clinical Trials, Chicago
- Endeavor Health, Skokie
- Evanston Premier Healthcare Research LLC, Skokie
VärbamineFaas 3
Vanused 18–99 · Kõik sood · Uuendatud 3. sept 2026 · NCT07684235Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Kailera Clinical Site, Springfield
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 3. sept 2026 · NCT07284875BRIDGE & Friends Trial
- University of Illinois Chicago, Chicago
VärbamineTerved vabatahtlikud oodatud
Vanused 50–79 · Kõik sood · Uuendatud 1. sept 2026 · NCT07798557Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- Endeavor Health, Skokie
VärbamineFaas 3
Vanused 18–99 · Kõik sood · Uuendatud 27. aug 2026 · NCT07575399Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.
- Illinois Institute of Technology, Chicago
VärbamineTerved vabatahtlikud oodatud
Vanused 21–74 · Kõik sood · Uuendatud 27. aug 2026 · NCT07566325A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Champaign
- Research Site, Chicago
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. aug 2026 · NCT07784725AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- Clinical Investigation Spec Gurnee, Gurnee
- Evanston Premier Hlthcr Res, Skokie
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 17. aug 2026 · NCT07509307Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Chicago
VärbamineFaas 3
Vanused 18–79 · Kõik sood · Uuendatud 10. aug 2026 · NCT07654361Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
- Jesse Brown VA Medical Center, Chicago
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. juuli 2026 · NCT06390345FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control
- Mile Square Health Center Chicago, Chicago
- Mile Square Health Center - Auburn Gresham, Chicago
- Mile Square Health Center - Englewood, Chicago
- ja veel 1
VärbamineFaas 2
Kõik vanused · Kõik sood · Uuendatud 10. juuli 2026 · NCT07332741Better Lifestyle Counseling for African American Women During Pregnancy
- University of Illinois at Chicago, Chicago
- University of Illinois at Chicago, Chicago
Värbamine
Vanused 18–40 · Naised · Uuendatud 9. juuli 2026 · NCT05234125People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists
- Northwestern Memorial Hospital, Chicago
VärbamineVaatlusuuring
Vanused 18–70 · Kõik sood · Uuendatud 17. märts 2026 · NCT07207148Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
- University of Chicago, Chicago
VärbamineFaas 3
Vanused 18–75 · Kõik sood · Uuendatud 14. nov 2025 · NCT06499857Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.